Monitoring of Early Changes of Circulating Tumor DNA in the Plasma of Rectal Cancer Patients Receiving Neoadjuvant Concomitant Chemoradiotherapy: Evaluation for Prognosis and Prediction of Therapeutic Response-Reference-Cited by-同舟云学术

Monitoring of Early Changes of Circulating Tumor DNA in the Plasma of Rectal Cancer Patients Receiving Neoadjuvant Concomitant Chemoradiotherapy: Evaluation for Prognosis and Prediction of Therapeutic Response

Published:2020-07-24 Issue: Volume:10 Page:
ISSN:2234-943X
Container-title:Frontiers in Oncology
language:
Short-container-title:Front. Oncol.

Author:

Pazdirek Filip,Minarik Marek,Benesova Lucie,Halkova Tereza,Belsanova Barbora,Macek Milan,Stepanek Lubomír,Hoch Jiri

Funder

Ministerstvo Zdravotnictví Ceské Republiky

Publisher

Frontiers Media SA

Subject

Cancer Research,Oncology

Reference58 articles.

1. Rectal cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up;Glynne-Jones;Ann Oncol.,2017

2. The Swedish rectal cancer registry;Pahlman;Br J Surg.,2007

3. Tumor regression grading after preoperative chemoradiotherapy for locally advanced rectal carcinoma revisited: updated results of the CAO/ARO/AIO-94 trial;Fokas;J Clin Oncol.,2014

4. Impact of tumor regression grade as a major prognostic factor in locally advanced rectal cancer after neoadjuvant chemoradiotherapy: a proposal for a modified staging system;Song;Cancers.,2018

5. Pathological features of rectal cancer after preoperative radiochemotherapy;Dworak;Int J Colorectal Dis.,1997

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Correlation between Plasma Circulating Tumor DNA and Radiographic Tumor Burden;The Journal of Molecular Diagnostics;2024-08

2. Clinical impact of circulating tumor DNA to track minimal residual disease in colorectal cancer patients. Hopes and limitations;ESMO Gastrointestinal Oncology;2024-06

3. Assessing circulating tumour DNA (ctDNA) as a prognostic biomarker in locally advanced rectal cancer: a systematic review and meta-analysis;International Journal of Colorectal Disease;2024-05-29

4. ctDNA as a predictor of outcome after curative resection for locally advanced rectal cancer: systematic review and meta‐analysis;Colorectal Disease;2024-05-27

5. The clinical application of ctDNA to predict response to neoadjuvant chemoradiotherapy in patients with locally-advanced rectal cancer;Biomarker Research;2023-09-19